You are here

Mary C. Tierney, MS
Vice President & Chief Content Officer, TriMed Media Group
Mary joined TriMed Media in 2003. She was the founding editor and editorial director of Health Imaging, Cardiovascular Business, Molecular Imaging Insight and CMIO, now known as Clinical Innovation + Technology. Prior to TriMed, Mary was the editorial director of HealthTech Publishing Company, where she had worked since 1991. While there, she oversaw four magazines and related online media, and piloted the launch of two magazines and websites. Mary holds a master’s in journalism from Syracuse University. She lives in East Greenwich, R.I., and when not working, she is usually running around after her family, taking photos or cooking.
 - Mary Tierney

When it comes to TAVR, what is good for patients is good for economics too. Or more specifically, what is good for Medicare patients with severe aortic stenosis at intermediate risk for surgery is good for reductions in U.S healthcare costs. The amount depends on where you live, with CMS reimbursing much higher on the East and West Coasts versus the center of the country with valve costs remaining the same.

 - Brian-Contos

With physicians and administrators ever more focused on high-quality medicine and the financial bottom line, what trends and strategies are shaping the future of the cardiovascular service line? Let’s take a look at the future forecast through the expert eyes of Brian Contos, an executive director of The Advisory Board Company. Is your program poised to take advantage of changing market dynamics such as outpatient care, reimbursement and payment policies? And what about implantables, MACRA patient-focused care and interventional procedures like Protected PCI?

 - Mary Tierney

Just-released studies shine more positive light on TAVR in terms of durability five years out and long-term survival, with women outpacing men by about 15 percent.

 - contos_brian_mary-t

What trends and strategies are shaping the future destiny of the cardiovascular service line? Take a look at the future forecast through the expert eyes of Brian Contos, an executive director with The Advisory Board Company. Is your program poised to take advantage of changing market dynamics such as outpatient care, reimbursement and payment policies? And what about implantables, MACRA, patient-focused care and interventional procedures?

 - Memorial Hospital

Delivering key images, reports and patient data to the point of diagnosis and care is the Holy Grail of radiology and many other specialties today. Having the correct information for the patient at the right time for the radiologist or referring physician starts with having the right viewer.

 - Mary Tierney

Not exactly. A recent study, the largest of its kind that tracked more than 1,000 children, found a 70 percent success rate using balloon aortic valvuloplasty (BAV) to treat isolated congenital aortic stenosis (AS).

 - Mary Tierney

Innovation in medicine is amazing, adding tests, devices, drugs and procedures to our arsenal all the time. We’re good at adding new options that are better, stronger and faster but often remiss in sunsetting old options. And it’s costing us millions each year in diagnosing acute MI patients as a recent JAMA Internal Medicine article points out.

 - Mary Tierney

U.S. scientists in July edited the DNA of a human embryo. It’s a first, it’s just the beginning and could someday mean the end of children born with hypertrophic cardiomyopathy. Imagine wiping out sudden cardiac death in young athletes someday.  

 - Mary Tierney

Unless you were lucky enough to be on an extended summer vacation, you know that CMS proposed to halt bundled payment programs for Episode Payment Models (EPMs) for MI and bypass surgery and the Cardiac Rehabilitation Incentive (CRI) payment model. (Public comment on the changes can be made through October 16th.)

 - Mary Tierney

3D printers have created the darnedest things: acoustic guitars that strum and guns that shoot, women’s high-heeled shoes, lights, clocks and even custom-fitted fabric.